Sang-Hee Cho[Author] - Search Results

Year	Number of Results
2002	4
2003	1
2004	2
2005	3
2006	2
2007	7
2008	7
2009	6
2010	8
2011	6
2012	10
2013	12
2014	8
2015	7
2016	7
2017	8
2018	9
2019	10
2020	10
2021	9
2022	6
2023	7
2024	3

1

Comparative Study on the Immunogenicity of COVID-19 mRNA Vaccines in Patients Receiving Adjuvant and Palliative Chemotherapy.

Choi HW, Jung Y, Kim UJ, Lee SC, Kwon JH, Kim H, Kim S, Lee Y, Shim HJ, Cho SH, Chung IJ, Hwang EC, Kang SJ, Bae WK, Kee SJ. Choi HW, et al. Among authors: cho sh. Chonnam Med J. 2024 Jan;60(1):69-77. doi: 10.4068/cmj.2024.60.1.69. Epub 2024 Jan 25. Chonnam Med J. 2024. PMID: 38304127 Free PMC article.

2

A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer.

Lee KW, Han SW, Kim TW, Ahn JB, Baek JY, Cho SH, Lee H, Kim JW, Kim JW, Kim TY, Hong YS, Beom SH, Cha Y, Choi Y, Kim S, Bang YJ. Lee KW, et al. Among authors: cho sh. Cancer Res Treat. 2024 Apr;56(2):590-601. doi: 10.4143/crt.2023.1117. Epub 2023 Dec 7. Cancer Res Treat. 2024. PMID: 38062706 Free PMC article. Clinical Trial.

3

Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis.

Kim HJ, Lee SH, Shim HJ, Bang HJ, Cho SH, Chung IJ, Hwang EC, Hwang JE, Bae WK. Kim HJ, et al. Among authors: cho sh. Front Oncol. 2023 Oct 10;13:1265240. doi: 10.3389/fonc.2023.1265240. eCollection 2023. Front Oncol. 2023. PMID: 37881486 Free PMC article.

4

Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial.

Keam B, Hong MH, Shin SH, Heo SG, Kim JE, Ahn HK, Lee YG, Park KU, Yun T, Lee KW, Kim SB, Lee SC, Kim MK, Cho SH, Oh SY, Park SG, Hwang S, Nam BH, Kim S, Kim HR, Yun HJ; KCSG TRIUMPH Investigators. Keam B, et al. Among authors: cho sh. J Clin Oncol. 2024 Feb 10;42(5):507-517. doi: 10.1200/JCO.22.02786. Epub 2023 Sep 12. J Clin Oncol. 2024. PMID: 37699162 Clinical Trial.

5

Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-α-TAK1-MMP9 axis.

Sun EG, Vijayan V, Park MR, Yoo KH, Cho SH, Bae WK, Shim HJ, Hwang JE, Park IK, Chung IJ. Sun EG, et al. Among authors: cho sh. Cell Death Discov. 2023 Apr 11;9(1):122. doi: 10.1038/s41420-023-01419-9. Cell Death Discov. 2023. PMID: 37041137 Free PMC article.

6

No association between genetically predicted C-reactive protein levels and colorectal cancer survival in Korean: two-sample Mendelian randomization analysis.

Choi CK, Yang JH, Shin MH, Cho SH, Kweon SS. Choi CK, et al. Among authors: cho sh. Epidemiol Health. 2023;45:e2023039. doi: 10.4178/epih.e2023039. Epub 2023 Mar 22. Epidemiol Health. 2023. PMID: 36996866 Free PMC article.

7

Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy.

Bang HJ, Shim HJ, Hwang JE, Bae WK, Chung IJ, Cho SH. Bang HJ, et al. Among authors: cho sh. Chonnam Med J. 2023 Jan;59(1):76-82. doi: 10.4068/cmj.2023.59.1.76. Epub 2023 Jan 25. Chonnam Med J. 2023. PMID: 36794240 Free PMC article.

8

Machine learning with in silico analysis markedly improves survival prediction modeling in colon cancer patients.

Lee CJ, Baek B, Cho SH, Jang TY, Jeon SE, Lee S, Lee H, Nam JS. Lee CJ, et al. Among authors: cho sh. Cancer Med. 2023 Mar;12(6):7603-7615. doi: 10.1002/cam4.5420. Epub 2022 Nov 7. Cancer Med. 2023. PMID: 36345155 Free PMC article.

9

DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis.

Kim JH, Park SY, Jeon SE, Choi JH, Lee CJ, Jang TY, Yun HJ, Lee Y, Kim P, Cho SH, Lee JS, Nam JS. Kim JH, et al. Among authors: cho sh. Theranostics. 2022 Jul 4;12(12):5258-5271. doi: 10.7150/thno.72037. eCollection 2022. Theranostics. 2022. PMID: 35910805 Free PMC article.

10

Dysadherin awakens mechanical forces and promotes colorectal cancer progression.

Park SY, Lee CJ, Choi JH, Kim JH, Lee WJ, Jang TY, Jeon SE, Kim JH, Cho SH, Lee JS, Nam JS. Park SY, et al. Among authors: cho sh. Theranostics. 2022 May 21;12(9):4399-4414. doi: 10.7150/thno.72354. eCollection 2022. Theranostics. 2022. PMID: 35673579 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

127 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Results by year